Pine Valley Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
10,622
-1,215
-10% -$1.24M 0.5% 53
2026
Q1
$10.9M Sell
11,837
-330
-3% -$335K 0.5% 49
2025
Q4
$13.1M Sell
12,167
-116
-0.9% -$111K 0.61% 37
2025
Q3
$9.37M Buy
12,283
+1,413
+13% +$1.05M 0.46% 56
2025
Q2
$8.47M Sell
10,870
-320
-3% -$249K 0.47% 54
2025
Q1
$9.24M Buy
11,190
+658
+6% +$548K 0.56% 43
2024
Q4
$8.13M Buy
10,532
+2,780
+36% +$2.3M 0.49% 46
2024
Q3
$6.87M Buy
7,752
+546
+8% +$491K 0.42% 57
2024
Q2
$6.52M Buy
7,206
+171
+2% +$137K 0.43% 58
2024
Q1
$5.47M Buy
7,035
+465
+7% +$331K 0.37% 65
2023
Q4
$3.83M Sell
6,570
-265
-4% -$155K 0.28% 76
2023
Q3
$3.67M Buy
6,835
+1,910
+39% +$984K 0.33% 70
2023
Q2
$2.31M Buy
4,925
+107
+2% +$44.9K 0.23% 106
2023
Q1
$1.78M Buy
+4,818
New +$1.62M 0.26% 88

Other funds holding LLY

Pine Valley Investments's LLY Position: Q2 2026 in Review

Pine Valley Investments reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $1.24M and leaving 10,622 shares worth $12.7M. The position accounts for 0.5% of the portfolio, ranked #53.

Pine Valley Investments first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.1M in Q4 2025. 2,668 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pine Valley Investments held 10,622 shares of Eli Lilly worth $12.7M as of Q2 2026.
  • Pine Valley Investments sold 1,215 Eli Lilly shares in Q2 2026, an estimated $1.24M.
  • Eli Lilly made up 0.5% of Pine Valley Investments's portfolio in Q2 2026, its #53 holding.
  • Pine Valley Investments first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • Pine Valley Investments's Eli Lilly position peaked at $13.1M in Q4 2025.
  • 2,668 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.